Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...
One Application Seeks European Commission Authorization; Other Application Would Facilitate Availability in Low- and Lower-Middle-Income Countries - - Both Applications Will Be Assessed in Parallel ...
The New Times on MSN
Rwandans react to planned six-month HIV prevention injection
The Rwanda Biomedical Center (RBC) said last week that the government plans to introduce lenacapavir, a long-acting ...
Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...
Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...
At the end of 2022, the last year for which CDC data was publicly available, there were 135,400 people living with HIV in ...
An AIDS drug already shown to help prevent spread of the virus in gay men also works for heterosexual men and women, two studies in Africa found.
Human Immunodeficiency Virus (HIV) is a virus that attacks the body’s immune system, specifically the CD4 (T) cells, which ...
The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...
Taken as prescribed, PrEP — shorthand for preexposure prophylaxis — is 99% effective in protecting people against sexual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results